2015
DOI: 10.1016/j.mce.2015.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet

Abstract: X. (2015). Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet. Molecular and Cellular Endocrinology, Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet AbstractHigh-fat (HF) diet-induced obesity is a major risk factor for the development of insulin resistance and hepatic steatosis. We examined the hypothesis that bardoxolone methyl (BM) would prevent the development of insulin resis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
23
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 53 publications
(1 reference statement)
4
23
0
Order By: Relevance
“…Additionally, these results are even more interesting if one takes into account that miR-1 and miR-155, described above as differentiating the response to stress of NET-KO and SWR/J mice from WT animals, regulate the expression of the gene encoding BDNF [30]. It correlates with data provided by Camer and co-workers, who have shown that the reduction of BDNF-TrkB signaling could result from a decrease of the BDNF level in the liver [55]. In turn, Tonra and colleagues presented evidence that BDNF improved blood glucose control [56].…”
Section: Discussionsupporting
confidence: 81%
“…Additionally, these results are even more interesting if one takes into account that miR-1 and miR-155, described above as differentiating the response to stress of NET-KO and SWR/J mice from WT animals, regulate the expression of the gene encoding BDNF [30]. It correlates with data provided by Camer and co-workers, who have shown that the reduction of BDNF-TrkB signaling could result from a decrease of the BDNF level in the liver [55]. In turn, Tonra and colleagues presented evidence that BDNF improved blood glucose control [56].…”
Section: Discussionsupporting
confidence: 81%
“…The IPGTT was conducted as previously described by our laboratory [29]. Briefly, mice were fasted overnight followed by an intraperitoneal injection of glucose (2 g/ kg).…”
Section: Intraperitoneal Glucose Tolerance Test (Ipgtt)mentioning
confidence: 99%
“…The IPGTT was conducted as we have previously described [31]. Briefly mice were fasted overnight followed by an intraperitoneal injection of glucose (0.5 g/kg;…”
Section: Intraperitoneal Glucose Tolerance Test (Ipgtt)mentioning
confidence: 99%